AMSBIO has announced a package of initiatives to support the Glycobiology research community following the recent announcement by Seikagaku Corporation that they plan to discontinue their research reagents and glycobiology biochemicals business as of September 30th 2011.
As a specialist in high purity reagents for glycobiology and glycoanalysis for over 20 years - AMSBIO has developed in-depth technical expertise and a broad range of products including a range of antibodies, enzymes, assays and standards for Proteoglycan and Glycosaminoglycan (GAG) research.
Alex Sim, CEO of AMSBIO commented: "To support users of Seikagaku research reagents, GAG antibodies and biochemicals, we have invested in inventory to enable us to supply researchers for the next 18-24 months."
He added: "In addition we are actively working on alternative products and to maintain our global reputation as being the premier supplier for Glycobiology research".
For more information, visit www.amsbio.com
As a specialist in high purity reagents for glycobiology and glycoanalysis for over 20 years - AMSBIO has developed in-depth technical expertise and a broad range of products including a range of antibodies, enzymes, assays and standards for Proteoglycan and Glycosaminoglycan (GAG) research.
Alex Sim, CEO of AMSBIO commented: "To support users of Seikagaku research reagents, GAG antibodies and biochemicals, we have invested in inventory to enable us to supply researchers for the next 18-24 months."
He added: "In addition we are actively working on alternative products and to maintain our global reputation as being the premier supplier for Glycobiology research".
For more information, visit www.amsbio.com
